PRODUCT DETAILS

About Svitinib 12.5 Capsule

SUNITINIB belongs to the class of medications called ‘antineoplastic agents’ used in treating gastrointestinal stromal tumors (cancer of the stomach, bowel, or esophagus) in which patients don’t respond to imatinib (another anticancer agent). It is also used to treat renal carcinoma (kidney cancer) that has spread to other parts of the body and advanced pancreatic neuroendocrine tumors (cancer that has affected hormone-producing cells in the pancreas).

SUNITINIB contains sunitinib. It acts by slowing down the growth of cancer cells by two processes. It interferes with the action of a protein that promotes cell division and thereby decreases cancer cell production. It can inhibit a process called angiogenesis, the development of blood supply to the cancer cells. This effect inhibits the nutrient supply to the cancer cells, thereby causing cancer cell death eventually.

Uses of Svitinib 12.5 Capsule

Gastrointestinal stromal cancer, kidney cancer, and pancreatic neuroendocrine tumors

Medicinal Benefits of Svitinib 12.5 Capsule

SUNITINIB is a targeted therapy used to treat advanced kidney cancer. It is also used in patients with kidney cancer to prevent recurrence after having kidney surgery. It is used to treat gastrointestinal stromal cancer that cannot be treated with imatinib, another anti-cancer medicine. It is used to manage pancreatic neuroendocrine tumors (cancer of hormone-producing cells of the pancreas) that cannot be treated with surgery. SUNITINIB can help to manage the above conditions if taken regularly as prescribed by the doctor.

Directions for Use

SUNITINIB is available in the form of tablets. You can take this medicine with or without food. The tablet should be swallowed as a whole with a glass of water. Do not chew, crush, or break the tablet. The dose and duration are given by the doctor based on your health condition.

Side Effects of Svitinib 12.5 Capsule

• Difficulty to breathe
• Increase in blood pressure
• Extreme tiredness
• Swelling caused by fluid under the skin and around the eye
• Pain or irritation in the mouth
• Mouth sores
• Dry mouth
• Taste disturbances
• Upset stomach
• Nausea
• Vomiting
• Diarrhea or constipation
• Abdominal pain
• Loss of appetite
• Decreased activity of thyroid gland (hypothyroidism)
• Dizziness
• Headache
• Nose bleeding
• Back pain
• Joint pain
• Yellowish discoloration of the skin
• Rash on the palms of the hands and soles of the feet
• Dryness of the skin
• Cough
• Fever
• Difficulty to sleep

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug-Drug Interaction:

SUNITINIB may interact with antifungal agents (ketoconazole and itraconazole), antibiotics (erythromycin, clarithromycin, and rifampicin), blood thinners (warfarin and acenocoumarol), a steroid medicine (dexamethasone), medicines used to treat fits (phenytoin, carbamazepine, and phenobarbital), and a herbal antidepressant (hypericum perforatum).

Safety Advice

ALCOHOL

Do not consume alcohol as it can increase the risk of side-effects.

 

PREGNANCY

SUNITINIB may cause harmful effects to the unborn baby when used in pregnant women. It is also advised to use reliable contraception to prevent pregnancy while using this medicine.

BREAST FEEDING

SUNITINIB may cause harmful effects to the nursing baby when given to breastfeeding mothers.

DRIVING

SUNITINIB may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy.

LIVER

SUNITINIB should be used with caution in patients with liver diseases.

KIDNEY

SUNITINIB should be used with caution in patients with kidney diseases.